Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Usefulness of serum anti-p53 antibody assay for lung cancer diagnosis.

Archives of pathology & laboratory medicine - 1 Dec 2011

Park Yongjung, Kim Yoonjung, Lee Jong-Han, Lee Eun Young, Kim Hyon-Suk

Abstract excerpt

CONTEXT: Some tumor markers, including carcinoembryonic antigen (CEA) and cytokeratin 19 fragment (CYFRA 21-1), are used for the detection of lung cancer; however, their use is limited because of low sensitivities and high false-positive rates. OBJECTIVES: To investigate the usefulness of an anti-p53 assay in detecting lung cancer and to compare the anti-p53 to CEA and CYFRA 21-1 tumor markers. DESIGN: Serum...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neoplasm
Share to Antigens, Neoplasm
Share to Carcinoembryonic Antigen

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Enzyme-Linked Immunosorbent Assay

Share to Immunoassay

Share to Keratin-19

Share to Mutant Proteins

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 22129186
DOI: 10.5858/arpa.2010-0717-OA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Usefulness of serum anti-p53 antibody assay for lung cancer diagnosis.PMID 22129186Read ↗

Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer.Semantic proximity Read ↗

Distinction of ALK fusion gene- and EGFR mutation-positive lung cancer with tumor markers.Semantic proximity Read ↗

[Serum CYFRA21-1 is Correlated with the Efficacy of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients Harboring EGFR Mutations].Semantic proximity Read ↗

Assessment of the potential diagnostic value of serum p53 antibody for cancer: a meta-analysis.Semantic proximity Read ↗

[Detection of oncogenic mutations in sputum and its diagnostic value of lung cancer].Semantic proximity Read ↗

Cytokeratin 19 fragment predicts the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor in non-small-cell lung cancer harboring EGFR mutation.Semantic proximity Read ↗

Prognostic value of CYFRA 21 - 1 and Ki67 in advanced NSCLC patients with wild-type EGFR.Semantic proximity Read ↗

Prognostic and predictive value of carcinoembryonic antigen and cytokeratin-19 fragments levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib.Semantic proximity Read ↗

Predictive and Prognostic Value of CYFRA 21-1 for Advanced Non-small Cell Lung Cancer Treated with EGFR-TKIs.Semantic proximity Read ↗

The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma.Semantic proximity Read ↗

p53 antibodies in the sera of lung cancer patients: comparison with p53 mutation in the tumour tissue.Semantic proximity Read ↗

[Clinical importance of serum anti-p53 antibodies as tumor markers].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.